NASDAQ:OVID - Ovid Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$2.93 -0.06 (-2.01 %)
(As of 12/19/2018 04:32 AM ET)
Previous Close$2.99
Today's Range$2.93 - $3.05
52-Week Range$2.93 - $11.45
Volume43,800 shs
Average Volume79,716 shs
Market Capitalization$73.96 million
P/E Ratio-0.87
Dividend YieldN/A
Beta1.03

Analyst Ratings

Ovid Therapeutics (NASDAQ:OVID) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for Ovid Therapeutics in the last 12 months. Their average twelve-month price target is $19.00, suggesting that the stock has a possible upside of 548.46%. The high price target for OVID is $27.00 and the low price target for OVID is $10.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $19.00$23.50$23.50$23.50
Price Target Upside: 548.46% upside415.35% upside281.49% upside169.19% upside

Ovid Therapeutics (NASDAQ:OVID) Consensus Price Target History

Price Target History for Ovid Therapeutics (NASDAQ:OVID)

Ovid Therapeutics (NASDAQ:OVID) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/17/2018Cantor FitzgeraldSet Price TargetBuy$10.00MediumView Rating Details
8/12/2018Piper Jaffray CompaniesSet Price TargetBuy$20.00LowView Rating Details
4/20/2018LADENBURG THALM/SH SHInitiated CoverageBuy$27.00MediumView Rating Details
4/1/2018CowenReiterated RatingBuyHighView Rating Details
5/30/2017CitigroupInitiated CoverageBuy ➝ Buy$21.00HighView Rating Details
5/30/2017William BlairInitiated CoverageOutperform ➝ OutperformHighView Rating Details
5/30/2017JMP SecuritiesInitiated CoverageMkt Outperform ➝ Outperform$26.00HighView Rating Details
(Data available from 12/19/2016 forward)
This page was last updated on 12/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel